Back

The impact of multimorbidity on cardiac remodelling in the UK Biobank

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Cardiac magnetic resonance in cardiomyopathies Morphology, Dimensions, Volumes and Mass ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Vijay Shyam-Sundar

Queen Mary University of London, London (United Kingdom of Great Britain & Northern Ireland)

8 More presentations in this session

Presentation thumbnail
Manganese-enhanced magnetic resonance imaging in diabetic cardiomyopathy
Doctor S. Joshi (Edinburgh, GB)
Abstract Slides Video
Presentation thumbnail
Additive effect of metabolic dysfunction-associated fatty liver disease on left ventricular function and global strain in type 2 diabetes mellitus patients: a 3.0 T CMR feature tracking study
Doctor X. Tang (Chengdu, CN)
Abstract Slides Video
Presentation thumbnail
Diabetes worsens the adverse association between myocardial diffuse fibrosis and left ventricular strain.
Doctor S. Chadalavada (London, GB)
Abstract Slides Video
Presentation thumbnail
Propensity score-matched analysis in isolated left ventricular dilation and non-ischaemic dilated cardiomyopathy
Doctor T. Goncalves (Toronto, CA)
Abstract Slides Video
Presentation thumbnail
Enhanced diagnostic accuracy of cardiovascular magnetic resonance in identifying heart failure with preserved ejection fraction through assessment of right ventricular systolic dysfunction
Assistant Professor K. Huang (Hsinchu, TW)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac magnetic resonance in cardiomyopathies

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Cardio-Kidney-metabolic overlap in HFpEF: cardiac structure and function, clinical outcomes, and response to sacubitril/valsartan in PARAGON-HF
thumbnail
Congress Presentation
Impact of multimorbidity on mortality in heart failure with mildly reduced and preserved ejection fraction
thumbnail
Congress Presentation
Multimorbidity increases risk of cardiovascular outcomes in permanent atrial fibrillation: data from the RACE II study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources